跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AQUAGEL DEFENSE 50 - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AQUAGEL DEFENSE 50
Authorized
STANDARD
AQUAGEL DEFENSE 50
lancome canada
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
460da145c1cafe65
Company
lancome canada
Type
Standard
Approval Details
Approval Id
460da145c1cafe65
Drug Approval Canada Name
AQUAGEL DEFENSE 50
Product Name
AQUAGEL DEFENSE 50
Status
Marketed
Status Date
2022-02-10
Original Market Date
2022-02-10
Din
02517159
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:80.00
Atc Original
D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION
Atc Name
d 02 ba 30
Aig Number
0451521073
Company Name
lancome canada
Company Address
4895 Hickmore, Montreal, Quebec, Canada, H4T 1K5
Active Ingredients
AVOBENZONE
3 % / W/W
HOMOSALATE
15 % / W/W
OCTISALATE
5 % / W/W
OCTOCRYLENE
7 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
460da145c1cafe65
Type
Standard
Back to Health Canada Approvals